Work

Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System

Year: 2025

Type: article

Source: International Journal of Dermatology

DOI: 10.1111/ijd.70082

Authors: Tung S. Tran, Duc V. Le, Jena C. Jacobs, Trang M. Nguyen, David A. Wetter, Giang H. Nguyen

Institutions: Mayo Clinic, Hanoi Medical University, Bassett Medical Center

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414473840

FWCI: 1.331

Cites: 4

Cited by: 1

Related to: